Fed. Circ. Affirms Dismissal Of AIDS Drug Antitrust Case

By Darcy Reddan (May 11, 2018, 6:21 PM EDT) -- A Federal Circuit panel affirmed Friday a California district court's ruling that AIDS Healthcare Foundation Inc. can't invalidate five patents for HIV treatments or support antitrust claims against Gilead Sciences Inc. because the foundation could not show it had any connection to the intellectual property that would warrant the action....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!